We are live on ! Find out more
LONA

LeonaBio Inc

70 hedge funds and large institutions have $43.3M invested in LeonaBio Inc in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 29 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,310% more call options, than puts

Call options by funds: $716K | Put options by funds: $21K

0.14% less ownership

Funds ownership: 5.77%5.63% (-0.14%)

9% less funds holding

Funds holding: 7770 (-7)

33% less capital invested

Capital invested by funds: $64.6M → $43.3M (-$21.3M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

50% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 14

62% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 29

Holders
70
Holders Change
-7
Holders Change %
-9.09%
% of All Funds
1.11%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
7
Increased
11
Reduced
29
Closed
14
Calls
$716K
Puts
$21K
Net Calls
+$695K
Net Calls Change
-$257K

LONA Hedge Fund Activity: Q3 2023 in Review

70 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in LeonaBio Inc (LONA) for Q3 2023, worth a combined $43.3M — down 33% from $64.6M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of LONA and 7 opened new positions — a net loss of 7 holders — while 29 trimmed existing stakes and 11 added.

The largest buyer was Barclays, adding an estimated $556K. The largest seller was Lynx1 Capital Management, exiting entirely with an estimated $571K sold.

  • 70 institutional investors held LeonaBio Inc (LONA) as of Q3 2023, down from 77 in Q2 2023.
  • Funds reported $43.3M of LeonaBio Inc stock for Q3 2023, down 33% quarter-over-quarter.
  • 7 funds opened new LeonaBio Inc positions in Q3 2023 and 14 closed out, a net change of -7 holders.
  • The largest LeonaBio Inc buyer in Q3 2023 was Barclays, an estimated $556K added.
  • The largest LeonaBio Inc seller in Q3 2023 was Lynx1 Capital Management, an estimated $571K sold.

Based on aggregated 13F filings for Q3 2023.